Lipoprotein(a): A Genetically Determined, Causal, and Prevalent

Por um escritor misterioso

Descrição

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Molecules, Free Full-Text
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Clinical Feature: The ABCs of Lipoprotein(a)
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Prevalence and clinical importance of high Lp(a) (lipoprotein[a])
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Pharmaceuticals, Free Full-Text
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3 - ScienceDirect
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis, European Journal of Medical Research
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA) - ScienceDirect
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
de por adulto (o preço varia de acordo com o tamanho do grupo)